Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 3.0B | 2.3B | 2.3B |
Cost of revenue | 1.3B | 1.4B | 1.4B | 1.4B |
Gross profit | 899M | 1.7B | 893M | 868M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | -21M |
Other operating expenses | 365M | 518M | 419M | 439M |
Operating income | 432M | 1.0B | 358M | 312M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 65M | 66M | 65M | 68M |
Other income expense | -64M | 708M | -2.3B | -76M |
Pretax income | 303M | 1.7B | -2.0B | 168M |
Tax provision | 65M | 440M | -322M | 26M |
Net income | 239M | 1.2B | -1.7B | 142M |
Basic EPS | 2.3 | 12.3 | -16.4 | 1.4 |
Diluted EPS | 2.3 | 12.3 | -16.4 | 1.4 |
Basic average shares | 100M | 101M | 102M | 103M |
Diluted average shares | 101M | 102M | 102M | 103M |
EBITDA | 460M | 1.1B | 503M | 452M |
Net income from continuing op. | 239M | 1.2B | -1.7B | 142M |
Minority interests | -4M | -2M | -3M | -1M |
Preferred stock dividends | — | — | — | — |